https://www.zonebourse.com/cours/action/OSE-IMMUNOTHERAPEUTICS-21120309/actualite/OSE-IMMUNOTHERAPEUTICS-inclusion-du-premier-patient-d-une-etude-de-phase-2-32062458/?utm_source=telegram&utm_medium=social&utm_campaign=share